ACQUISITION News
Roche Acquires PathAI for $750M Upfront to Boost Diagnostics AI
Roche Holding AG is acquiring PathAI for an upfront payment of $750 million, with potential milestone payments up to $300 million. This strategic acquisition aims to bolster Roche's diagnostics AI cap
Thermo Fisher Scientific Acquires Clario to Bolster AI Clinical Trial Capabilities
Thermo Fisher Scientific has completed its acquisition of Clario, a clinical trial technology provider, and subsequently raised its full-year revenue and EPS guidance. The deal is expected to signific
Roche Boosts AI for Pharma: Launches Factory, Acquires SAGA Diagnostics
Roche has announced the launch of its AI factory, powered by NVIDIA Blackwell GPUs, to accelerate the development of new therapeutics and diagnostics. Concurrently, Roche entered into a definitive agr
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
AI leader Anthropic is expanding its presence in the life sciences sector by acquiring New York-based startup Coefficient Bio for approximately $400 million in an all-stock deal. Coefficient Bio, a st
Anthropic Acquires Coefficient Bio for $400M+ in AI Drug Discovery Push
AI research company Anthropic has acquired Coefficient Bio, a stealth biotech AI startup, in a stock deal valued over $400 million. This strategic acquisition aims to bolster Anthropic's capabilities
Anthropic's $400M Bold Bet on Coefficient Bio Signals a Critical Shift in AI Drug Discovery
Anthropic has acquired Coefficient Bio, a stealth-mode biotech AI startup, for over $400 million in stock. This acquisition, involving a team of former Genentech computational biology researchers, sig
Anthropic's $400M Bet on Coefficient Bio for AI Drug Discovery
Anthropic has acquired Coefficient Bio, a stealth-mode biotech AI startup, in an all-stock deal valued at just over $400 million. This acquisition signals a critical shift where frontier AI labs aim t
Anthropic's $400M Bet on Coefficient Bio Signals AI Drug Discovery Shift
Anthropic has acquired Coefficient Bio for over $400 million in an all-stock deal, reflecting the strategic value of biology-native AI expertise. This acquisition marks a shift for Anthropic to build